The European Commission recently approved AUCATZYL (obecabtagene autoleucel – obe-cel), marking the 10th product approval for AGC Biologics’ Milan site from the EMA or the U.S. FDA. Read more below: https://lnkd.in/e4jpvaBu #biologics #celltherapy #carttherapy
Mantell Associates
Executive Search Services
City of London, England 156,756 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
Get directions
150 Minories
City of London, England EC3N 1LS, GB
-
Get directions
2 S Biscayne Blvd
Miami, Florida 33131, US
Employees at Mantell Associates
Updates
-
Apply now! Head of Business Development - Biotech - European Union. Mantell Associates is partnered with a high-growth and innovation-focused biotech company, who is currently searching for a strategic and commercially driven Head of Business Development to lead all partnership and growth activities across the European market. Apply for this role online - https://lnkd.in/eMMMir6d - or contact Abbie Mousley on +44 (0)20 3854 7700. #bdjobs #businessdevelopment #biotechjobs
-
-
Joshua Tob-Ogu discusses how AI’s influence in the molecular space is expanding from isolated breakthroughs, to industry-wide transformation. Whether in biotech startups or big pharma, AI is driving faster experimentation, lower costs, and deeper insights at the molecular level. Read more below: https://lnkd.in/eFCDFT6B #ai #molecules #chemicals
-
Bora Pharmaceuticals, a global pharmaceutical manufacturer, is making significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, MN. Bora acquired the site in 2024 as part of its $210 million acquisition of Upsher-Smith Laboratories, expanding its U.S. manufacturing footprint. Read more below: https://lnkd.in/eRvqtUrk #pharmamanufacturing #pharmanews #osd
-
Last Friday our Q2 top performers celebrated with our quarterly Lunch Club in London! It was a great afternoon starting with an amazing lunch at Los Mochis in the City, followed by cocktails and competitive shuffleboard at Players Social in Spitalfields! Huge congrats to everyone who attended, well deserved George Hebden Lee, Robin Mantell, George Watts, Serena Vigano, Maddy Savva, Siobhan McLoughlin and Jamie Peters. Our Lunch Club is designed to celebrate success and spend time out of the office as a team - well done everyone, we're already looking forward to the next one! #recruitmentlondon #recruitmentincentives #incentives
-
When Jazz Pharmaceuticals' incoming CEO Renée Galá takes the reins at the drugmaker next week, she'll have a brand-new launch to manage. Read more below: https://lnkd.in/gXE7VuBP #pharmanews #braincancer #fda
-
Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout that coincides with disappointing obesity sales and a leadership shake-up. Read more below: https://lnkd.in/e3kmH24W #biotechnews #obesitydrugs #drugsales
-
Biotech backer OrbiMed has raised $1.86 billion in commitments for its fifth fund aimed at “growth-oriented healthcare companies.” Read more below: https://lnkd.in/gySjtG7j #biotechnews #biotechequity #funding
-
Today we were pleased to welcome Abbie Mousley to the MA team as our newest Senior Associate! Abbie brings over 3 years recruitment experience in the Life Science space, and has joined our Biologics team. We look forward to seeing her impact here at MA - welcome! #welcome #recruitment #londonrecruitment
-
-
4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. Read more below: https://lnkd.in/eS7p9YPz #biotechnews #genetherapy #dme